The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development. RESI is uniquely cross-border and cross-domain, connecting start-ups with 10 categories of global investors across the silos of drugs, devices, diagnostics and digital health (4 Ds). RESI caters to both the earliest stage start-ups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding. RESI is a unique and powerful tool for sourcing assets and advancing innovation across early-stage life science and healthcare.

Life Science Nation (LSN) is hosting RESI Boston across 3-days from September 18th – 20th in a hybrid format. The first day on September 18th is onsite at the Boston Park Plaza Hotel in Massachusetts, USA, with 1-1 partnering meetings, onsite investor panels, workshops, exhibition, and pitch sessions. Followed are two days of virtual 1-1 partnering on September 19th – 20th.